Sandy Liebhard

Sandy A. Liebhard, a founding partner at Bernstein Liebhard LLP, has successfully represented plaintiffs in complex litigations for more than 20 years. As dedicated consumer advocates, Mr. Liebhard and his fellow attorneys have taken on some of the largest corporate interest in the nation in cases involving dangerous pharmaceuticals, faulty medical devices and defective consumer products. As an author for RXInuryHelp.com, Mr. Liebhard has written extensively on the litigation involving proton pump inhibitors (Nexium, Prilosec, PrevAcid, etc.) and kidney injuries; Risperdal and gynecomastia; the Bair Hugger forced air warming blanket; talcum powder and ovarian cancer; transvaginal mesh; power morcellators; defective hip implants; and more.

Mr. Liebhard is a 1988 graduate of Brooklyn Law School. He is admitted to the Bar of the State of New York, as well as the United States District Courts for the Southern and Eastern Districts of New York.


“Low T” Testosterone Drugs May Not Benefit Most Men, FDA Says in September Review

AndroGel and other testosterone treatments may not benefit men without abnormally low levels of the hormone, despite manufacturer claims that they are effective in treating common symptoms of aging, the U.S. Food and Drug Administration (FDA) said this week. The … Continue reading

Boston Campaigner Accused of “Defaming” Karl Storz Power Morcellator

The Karl Storz Group has threatened to take legal action against a Boston man whose efforts to end power morcellator surgery in the U.S. have created negative publicity for its Rotocut device, according to The Cancer Letter.com. A report on … Continue reading

Ethicon Case Heads to Trial in Transvaginal Mesh Litigation

A federal Ethicon litigation has begun its second trial for a transvaginal mesh lawsuit in the Southern District of West Virginia, where thousands of similar claims have been filed against the Johnson & Johnson subsidiary. The CharlestonDailyMail.com reported this week … Continue reading

Ties to Power Morcellator Manufacturer Prompt Doctor To Step Down from FDA Panel

A specialist in minimally-invasive gynecological surgery stepped down from a U.S. Food & Drug Administration (FDA) advisory panel after it was disclosed that he had served as a paid consultant to a major manufacturer of power morcellators. However, the doctor … Continue reading

GranuFlo Plaintiffs Eye Fresenius Corporate Integrity Agreement

Plaintiffs in thousands of GranuFlo and NaturaLyte lawsuits have asked a Massachusetts federal judge to compel Fresenius Medical Care North America to turn over all documents pertaining to a Corporate Integrity Agreement the company struck with the federal government in … Continue reading

Older Adults Taking Risperdal May Run Greater Risk for Kidney Problems, Study Finds

A new study finds that older patients taking Risperdal, an antipsychotic drug approved to treat schizophrenia and other conditions, may be more likely to develop acute kidney injuries. Research published August 19th in Annals of Internal Medicine showed individuals also … Continue reading

Request for Mirena Brain Injury Litigation Denied by Federal Panel

A federal panel has decided not to centralize lawsuits alleging Mirena brain injuries in a federal multidistrict litigation, stating that not enough similar claims have been filed over the IUD, according to recent reports. The U.S. Judicial Panel on Multidistrict Litigation (JPML) … Continue reading

Fresenius Opposes GranuFlo Plaintiffs’ Motion to Turn over Docs Unrelated to Dialysis Drug

Plaintiffs involved in a federal GranuFlo litigation have asked Fresenius to turn over all documents pertaining to a corporate integrity agreement it entered more than a decade ago, whether or not they involved the dialysis medication, according to recent reports. … Continue reading

Testosterone Treatment Litigation Progressing, As Judge Issues Order Outlining Plaintiffs’ Leadership Structure

Even as U.S. health regulators continue to review the safety of low testosterone therapy, the federal judge overseeing lawsuits involving AndroGel and similar drugs continues to move the litigation forward. In an Order issued on August 1st, U.S. District Judge … Continue reading

Children on Medicaid often Juggle Risperdal and other Psychotropic Meds, Study Suggests

More children in the Medicaid program are being prescribed second-generation antipsychotics like Risperdal simultaneously with stimulants, anti-depressants and other medications, according to a recent study. The results of research published recently in the Journal of the American Academy of Child … Continue reading

Follow Us

RXInjuryHelp.com on Google+  RXInjuryHelp.com on Facebook  RXInjuryHelp.com on LinkedIn  RXInjuryHelp.com on Twitter  RXInjuryHelp.com on YouTube  RXInjuryHelp.com on Pinterest

Skip to content